Results 121 to 130 of about 92,393 (132)
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
, 2016 Kenney Roy Roodakker, Tamador Elsir, Per-Henrik Edqvist, Daniel Hägerstrand, Joseph W. Carlson, M Łysiak, Roger Henriksson, Fredrik Pontén, Johan Rosell, Peter Söderkvist, Roger Stupp, Elena Tchougounova, Monica Nistér, Annika Malmström, Anja Smits +14 moreopenalex +2 more sourcesIDH wild type low grade gliomas: Who seeks shall find [PDF]
, 2017 Anna Mandrioli, Enrico Franceschi, Santino Minichillo, Antonella Mura, A. Tosoni, Dario de Biase, Elena Zunarelli, Giovanni Lanza, Daniela Bartolini, Enrico Maria Silini, Giovanni Tallini, Luigi Cirillo, Carlo Bortolotti, Daniela Danieli, Stefania Bartolini, Alexandro Paccapelo, Alba A. Brandes +16 moreopenalex +1 more sourceTMOD-45. DEFINING THE ROLE OF MUTANT IDH IN GLIOMA INITIATION [PDF]
, 2017 Beatrice Philip, Mark R. Silvis, Diana Yu, Clifford Shin, James P. Robinson, Joshua A. Sonnen, Adam Welker, Matthew W. VanBrocklin, Howard Colman, Sheri L. Holmen +9 moreopenalex +1 more sourceT2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project
, 2017 Sohil H. Patel, Laila Poisson, Daniel J. Brat, Yueren Zhou, Lee Cooper, Matija Snuderl, Cheddhi Thomas, Ana M. Franceschi, Brent Griffith, Adam E. Flanders, John G. Golfinos, S. Andrew, Rajan Jain +12 moreopenalex +1 more source